Latest News about INCY
Recent news which mentions INCY
This fund beats the S&P 500 by using just 75 of its components. Here’s how it works.
December 08, 2022
From MarketWatch
7 Cash-Rich Stocks to Buy for Peace of Mind
November 04, 2022
From InvestorPlace
2 Biotech Stocks That Could Make You Richer
November 04, 2022
From Motley Fool
Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm'
October 17, 2022
From Benzinga
2 Cathie Wood Stocks That Are Beating the Market This Year
October 07, 2022
From Motley Fool
Incyte Acquires Villaris Therapeutics, Deepening Portfolio For Immune-Mediated Dermatologic Diseases
October 03, 2022
Tickers
INCY
From Benzinga
MorphoSys' Monjuvi Shows Long-Term Durable Response In Blood Cancer Settings
September 29, 2022
From Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
From Benzinga
20 value stocks whose growth potential is overlooked by investors
September 12, 2022
From MarketWatch
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 26, 2022
From Benzinga
Incyte Gets FDA Nod For Hematologic Malignancies Candidate
August 26, 2022
Tickers
INCY
From Benzinga
4 Growth Stocks to Buy and Hold Forever
August 12, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
August 03, 2022
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Twitter And 3 Other Stocks Insiders Are Selling
July 12, 2022
From Benzinga
From Motley Fool
From Benzinga
7 Defensive Stocks to Buy for a Bear Market
June 27, 2022
From InvestorPlace